Lip GYH - Search Results

1

Ambulatory blood pressure and long-term risk for atrial fibrillation.

Tikhonoff V, Kuznetsova T, Thijs L, Cauwenberghs N, Stolarz-Skrzypek K, Seidlerová J, Malyutina S, Gilis-Malinowska N, Swierblewska E, Kawecka-Jaszcz K, Filipovský J, Narkiewicz K, Lip GYH, Casiglia E, Staessen JA; European Project On Genes in Hypertension (EPOGH) Investigators. Tikhonoff V, et al. Among authors: lip gyh. Heart. 2018 Aug;104(15):1263-1270. doi: 10.1136/heartjnl-2017-312488. Epub 2018 Feb 9. Heart. 2018. PMID: 29440183

2

Antiarrhythmics in atrial fibrillation.

Freestone B, Lip GY. Freestone B, et al. Curr Opin Investig Drugs. 2002 Jan;3(1):84-8. Curr Opin Investig Drugs. 2002. PMID: 12054078 Review.

3

A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.

Kamath S, Blann AD, Chin BS, Lanza F, Aleil B, Cazenave JP, Lip GY. Kamath S, et al. Eur Heart J. 2002 Nov;23(22):1788-95. doi: 10.1053/euhj.2002.3259. Eur Heart J. 2002. PMID: 12419299

4

Atrial fibrillation: should we target platelets or the coagulation pathway?

Tan KT, Lip GY. Tan KT, et al. Card Electrophysiol Rev. 2003 Dec;7(4):370-1. doi: 10.1023/B:CEPR.0000023141.17553.f1. Card Electrophysiol Rev. 2003. PMID: 15071256 Review.

5

Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.

Conway DS, Buggins P, Hughes E, Lip GY. Conway DS, et al. Am Heart J. 2004 Sep;148(3):462-6. doi: 10.1016/j.ahj.2004.01.026. Am Heart J. 2004. PMID: 15389233

6

Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.

Lip GY, Pearce LA, Chin BS, Conway DS, Hart RG. Lip GY, et al. Heart. 2005 Jun;91(6):759-63. doi: 10.1136/hrt.2004.036160. Heart. 2005. PMID: 15894770 Free PMC article. Clinical Trial.

7

Antithrombotic treatment in atrial fibrillation.

Lip GY, Boos CJ. Lip GY, et al. Heart. 2006 Feb;92(2):155-61. doi: 10.1136/hrt.2005.066944. Epub 2005 Sep 13. Heart. 2006. PMID: 16159980 Free PMC article. Review.

8

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.

Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC. Heeringa J, et al. Eur Heart J. 2006 Apr;27(8):949-53. doi: 10.1093/eurheartj/ehi825. Epub 2006 Mar 9. Eur Heart J. 2006. PMID: 16527828

9

Blood pressure measurement in atrial fibrillation: goodbye mercury?

Watson T, Lip GY. Watson T, et al. J Hum Hypertens. 2006 Sep;20(9):638-40. doi: 10.1038/sj.jhh.1002031. Epub 2006 Apr 13. J Hum Hypertens. 2006. PMID: 16617306 No abstract available.

10

Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study.

Lee KW, Blann AD, Jolly K, Lip GY; BRUM Investigators. Lee KW, et al. Heart. 2006 Dec;92(12):1732-8. doi: 10.1136/hrt.2006.092163. Epub 2006 Jun 28. Heart. 2006. PMID: 16807272 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,423 results

Search Page